Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v2-FR Version v2-FR
Language French French
Date Updated 2018-10-12 2018-10-12
Drug Identification Number 02194201 02194201
Brand name TEVA-NYSTATIN TEVA-NYSTATIN
Common or Proper name NYSTATIN NYSTATIN
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients NYSTATIN NYSTATIN
Strength(s) 100000UNIT 100000UNIT
Dosage form(s) SUSPENSION SUSPENSION
Route of administration ORAL ORAL
Packaging size 24ML 24ML
ATC code A07AA A07AA
ATC description INTESTINALANTIINFECTIVES INTESTINALANTIINFECTIVES
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date
Actual discontinuation date 2018-06-30 2018-06-30
Remaining supply date 2018-07-30 2018-07-30
Discontinuation status Discontinued Discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments 100ML and 1L Active 100ML and 1L Active
Health Canada comments